20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Brain Hemorrhage, Cerebral in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Falck, JR; Gao, Y; Guo, AM; Han, X; Koehler, RC; Lan, X; Li, Q; Liu, X; Wan, J; Wang, J; Yang, Z; Zang, W; Zhao, X | 1 |
Bandou, K; Cambj-Sapunar, L; Doi, M; Harder, DR; Kametani, S; Miyata, N; Okuyama, S; Omura, T; Roman, RJ; Sato, M; Seki, T; Tanaka, Y; Taniguchi, K | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis.
Topics: Animals; Cerebral Hemorrhage; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic | 2019 |
Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Topics: Animals; Brain; Carotid Arteries; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Collagenases; Cytochrome P-450 CYP4A; Formamides; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Isoenzymes; Male; Morpholines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Stroke | 2005 |